ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Liver Diseases, Alcoholic

  • A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 65 Years With Alcohol-related Liver Disease
  • MRG-001 in Patients With Alcoholic Hepatitis
  • Alcohol, Gut Leakiness, & Liver Disease
  • Alcoholic Liver Disease and the Gut Microbiome
  • Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease
  • Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease
  • Meta-Analysis of Drug Therapy in Patients With Severe Alcoholic Hepatitis
  • Effect of Probiotics on Gut-Liver Axis of Alcoholic Hepatitis
  • RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure
  • Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone
  • Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
  • Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
  • A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
  • Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease
  • Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis
  • Effect of Candesartan in Alcoholic Liver Fibrosis
  • Effects of SAMe in Patients With Alcoholic Liver Disease
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group